[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GR900100489A - Συνθέσεις χρήσιμοι ως αντισυλληπτικά για άνδρες. - Google Patents

Συνθέσεις χρήσιμοι ως αντισυλληπτικά για άνδρες.

Info

Publication number
GR900100489A
GR900100489A GR900100489A GR900100489A GR900100489A GR 900100489 A GR900100489 A GR 900100489A GR 900100489 A GR900100489 A GR 900100489A GR 900100489 A GR900100489 A GR 900100489A GR 900100489 A GR900100489 A GR 900100489A
Authority
GR
Greece
Prior art keywords
men
androgenetic
melatonin
hormone
contraception method
Prior art date
Application number
GR900100489A
Other languages
English (en)
Other versions
GR1002142B (en
Inventor
Michael Cohen
Original Assignee
Michael Cohen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Michael Cohen filed Critical Michael Cohen
Publication of GR900100489A publication Critical patent/GR900100489A/el
Publication of GR1002142B publication Critical patent/GR1002142B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Μέθοδος αντισυλλήψεως δια τον άνδρα περιλαμβάνει την χοργήγησιν συνδυασμού μελατονίνης και ανδρογενετικής ορμόνης εις αντισυλληπτικώς αποτελεσματικήν ποσότητα. Προαιρετικώς δύναται η μελατονίνη και η ανδρογενετική ορμόνη να συνδυάζονται και μετά προεμμηνορροϊκώς δραστικής ενώσεως. Η χορήγησις μελατονίνης και ανδρογενετικής ορμόνης παρέχει επίσης μέθοδον παρεμποδίσεως του καρκίνου του προστάτου εις τους άνδρας. ω
GR900100489A 1989-06-27 1990-06-26 Contraception method for men GR1002142B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US37179489A 1989-06-27 1989-06-27

Publications (2)

Publication Number Publication Date
GR900100489A true GR900100489A (el) 1991-11-15
GR1002142B GR1002142B (en) 1996-02-15

Family

ID=23465430

Family Applications (1)

Application Number Title Priority Date Filing Date
GR900100489A GR1002142B (en) 1989-06-27 1990-06-26 Contraception method for men

Country Status (17)

Country Link
EP (1) EP0479867B1 (el)
JP (1) JPH07507037A (el)
CN (1) CN1048327A (el)
AR (1) AR246870A1 (el)
AT (1) ATE137970T1 (el)
AU (1) AU639467B2 (el)
CA (1) CA2059138A1 (el)
DD (2) DD299619A5 (el)
DE (1) DE69027028T2 (el)
EG (1) EG19390A (el)
GR (1) GR1002142B (el)
IL (1) IL94869A (el)
IN (1) IN171596B (el)
NZ (1) NZ234210A (el)
PT (1) PT94493A (el)
WO (1) WO1991000095A1 (el)
ZA (1) ZA905020B (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE141051T1 (de) * 1992-04-07 1996-08-15 Neurim Pharma 1991 Verwendung von melatonin zur herstellung eines arzneimittels zur behandlung der gutartigen prostatahyperplasie
US5401669A (en) * 1993-05-13 1995-03-28 Memc Electronic Materials, Spa Process for the preparation of silicon wafers having controlled distribution of oxygen precipitate nucleation centers
CA2222625A1 (en) * 1995-06-07 1996-12-19 Merck & Co., Inc. Treatment and prevention of prostatic disease
DE19825591A1 (de) * 1998-06-09 1999-12-23 Jenapharm Gmbh Pharmazeutische Kombinationen zum Ausgleich eines Testosteron-Defizits beim Mann mit gleichzeitigem Schutz der Prostata
GB9813278D0 (en) * 1998-06-20 1998-08-19 Medical Res Council Male contraceptive
US6117441A (en) * 1998-07-02 2000-09-12 The Population Council, Inc. Silicone core long term androgen delivery implant
US6119870A (en) * 1998-09-09 2000-09-19 Aec Oil Sands, L.P. Cycloseparator for removal of coarse solids from conditioned oil sand slurries
RU2616252C2 (ru) * 2015-08-04 2017-04-13 Общество с ограниченной ответственностью "Научно-внедренческий центр Агроветзащита" Способ регулирования полового поведения самцов млекопитающих

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 101, no. 5, 30th July 1984, page 97, abstract no. 33680d, Columbus, Ohio, US; M. RODRIGUEZ et al.: "Effect of pineal indoles and testosterone on sexual behavior in the rat", & REV. ESP. FISIOL. 1984, 40(1), 31-5 *
CHEMICAL ABSTRACTS, vol. 103, no. 19, 5th March 1986, page 190, abstract no. 207248c, Columbus, Ohio, US; L.K. MALENDOWICZ et al.: "Testosterone and melatonin effects on adrenal cortex of orchiectomized and pinealectomized rats", & EXP. CLIN. ENDOCRINOL. 1985, 85(3), 283-8 *
CHEMICAL ABSTRACTS, vol. 107, no. 19, 9th November 1987, page 103, abstract no. 169223p, Columbus, Ohio, US; S. OAKNIN et al.: "Implantation of melatonin in mediobasal hypothalamus enhances the effect of testosterone negative feed-back on LH secretion", & ENDOCRINOLOGIA (BARCELONA) 1987, 34(2), 42-5 *
CHEMICAL ABSTRACTS, vol. 108, no. 19, 9th May 1988, page 110, abstract no. 161875c, Columbus, Ohio, US; M.K. VAUGHAN et al.: "Influence of melatonin on the testicular regression induced by subcutaneous testosterone pellets in male rats kept in long or short photoperiod", & J. REPROD. FERTIL. 1988, 82(1), 277-84 *
CHEMICAL ABSTRACTS, vol. 97, no. 23, 6th December 1982, page 111, abstract no. 193558x, Columbus, Ohio, US; C.I. SISK et al.: "Daily melatonin injections mimic the short day-induced increase in negative feedback effects of testosterone on gonadotropin secretion in hamsters", & BIOL. REPROD. 1982, 27(3), 602-8 *

Also Published As

Publication number Publication date
CN1048327A (zh) 1991-01-09
DE69027028D1 (de) 1996-06-20
ATE137970T1 (de) 1996-06-15
JPH07507037A (ja) 1995-08-03
AU639467B2 (en) 1993-07-29
WO1991000095A1 (en) 1991-01-10
DE69027028T2 (de) 1996-09-26
IN171596B (el) 1992-11-21
CA2059138A1 (en) 1990-12-28
EG19390A (en) 1995-01-31
PT94493A (pt) 1991-02-08
EP0479867B1 (en) 1996-05-15
AR246870A1 (es) 1994-10-31
IL94869A (en) 1994-10-07
GR1002142B (en) 1996-02-15
NZ234210A (en) 1994-10-26
DD299619A5 (de) 1992-04-30
AU5968390A (en) 1991-01-17
ZA905020B (en) 1991-04-24
DD297327A5 (de) 1992-01-09
EP0479867A1 (en) 1992-04-15

Similar Documents

Publication Publication Date Title
PT87053A (pt) Processo para a preparacao de composicoes contraceptivas contendo meletonina e metodo para efectuar a contracepcao
NO303527B1 (no) Ïstrogenholdig medikament og anordning for transdermal administrering derav
DE68928897D1 (de) Verfahren und system zur empfängnisverhütung
ATE290836T1 (de) Intravaginal-ringe mit einsetzbarem medikamentenenthaltenden kern
NO931766L (no) Topiske preparater for transdermal avlevering av forloeperlegemiddelderivater av morfin
NO20001287L (no) Farmasøytisk blanding for behandling av dysmenoré og for tidlig fødsel
NO982815D0 (no) Ultralav dose orale preventiver med mindre menstrasjonsbl°dning og vedvarende virkninsfullhet
BR9709934A (pt) Kit de terapia de reposição hormonal e/ou contraceptivo uso de unidades de dosagem diária consistindo essecialmente de um progestogênio e processo de preparação de um sistema de liberação de droga
PL327182A1 (en) Method of preventing conception among female mammals through combined application of gestagen and oestrogen and combination of active agent therefor
BG101553A (en) Progesterone antagonist and antiestrogenous active compounds of general application for female contraceptives
IL133762A0 (en) Transdermal therapeutic system (tts) for the administration of levonorgestral
DE69731882D1 (de) Transdermal verabreichtes dextromethorphan als hustenmittel
GR900100489A (el) Συνθέσεις χρήσιμοι ως αντισυλληπτικά για άνδρες.
ATE356637T1 (de) Supramolekulare komplexe enthaltende arzneimittel
DK1280558T3 (da) Halvfast indgivelsesvehikel og farmaceutiske sammensætninger
NO20005145L (no) FremgangsmÕte for behandling av fertilitetsproblemer
NO931208L (no) Formuleringer for transdermale kontraseptiver, samt fremgangsmaater og innretninger for tilfoersel av slike
IE831429L (en) Method of treating navicular disease in horses
MX9604426A (es) Reduccion de irritacion de la piel durante el surtido por electrotransporte.